Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer

被引:191
作者
Lee, Yuan-Chin Amy
Cohet, Catherine
Yang, Yu-Ching [2 ]
Stayner, Leslie [3 ]
Hashibe, Mia
Straif, Kurt [1 ]
机构
[1] Int Agcy Res Canc, Carcinogen Identificat & Evaluat Grp, F-69008 Lyon, France
[2] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
关键词
Cigarette smoking; liver cancer; meta-analysis; HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA PATIENTS; T1 GENETIC POLYMORPHISMS; S-TRANSFERASE M1; RISK-FACTORS; ALCOHOL-CONSUMPTION; C VIRUS; TOBACCO SMOKING; FOLLOW-UP; VIRAL-HEPATITIS;
D O I
10.1093/ije/dyp280
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Methods A meta-analysis of previous epidemiologic studies may help to clarify the potential association. We identified 38 cohort studies and 58 case-control studies in a systematic literature search for studies on liver cancer and cigarette smoking. The meta-relative risk (mRR) of liver cancer and dose-response trends were calculated. Tests for heterogeneity, publication bias assessment and influence analyses were performed. Results Compared with never smokers, the adjusted mRR was 1.51 [95% confidence interval (CI) 1.37-1.67] for current smokers and 1.12 (95% CI 0.78-1.60) for former smokers. The increased liver cancer risk among current smokers appeared to be consistent in strata of different regions, study designs, study sample sizes and publication periods. Conclusion The results of our meta-analysis show that tobacco smoking is associated with liver cancer development, which supports the conclusion by the IARC Monograph. This conclusion has an important public health message for areas with high smoking prevalence and high liver cancer incidence such as China.
引用
收藏
页码:1497 / 1511
页数:15
相关论文
共 121 条
  • [1] CIGARETTE-SMOKING AND CANCER MORTALITY RISK IN JAPANESE MEN AND WOMEN - RESULTS FROM REANALYSIS OF THE 6-PREFECTURE COHORT STUDY DATA
    AKIBA, S
    HIRAYAMA, T
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 87 : 19 - 26
  • [2] [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V59, P1
  • [3] [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1
  • [4] [Anonymous], 1978, IARC Monogr Eval Carcinog Risk Chem Man, V17, P1
  • [5] [Anonymous], 2001, IARC Monogr Eval Carcinog Risks Hum, V78, P1
  • [6] [Anonymous], 1986, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, V38, P1
  • [7] [Anonymous], 2004, HLTH CONS SMOK REP S
  • [8] [Anonymous], 1987, IARC Monographs, V7, P1, DOI DOI 10.1002/14356007.A04
  • [9] [Anonymous], 2004, INT AGENCY RES CANC, V83, P1
  • [10] AUSTIN H, 1986, CANCER RES, V46, P962